Interaction between human leukocyte elastase and chondroitin sulfate.

Area of Science:

• Biochemistry
• Biomaterials Science
• Rheumatology

Background:

• Articular cartilage degradation is mediated by enzymes like human leukocyte elastase.
• Chondroitin sulfate is a key component of cartilage extracellular matrix.
• Chondroprotective agents are used therapeutically for cartilage-related conditions.

Purpose of the Study:

• To investigate the interaction between chondroitin sulfate and human leukocyte elastase.
• To determine the kinetic mechanism of inhibition.
• To identify structural features of chondroitin sulfate that enhance inhibitory activity against cartilage degradation.

Main Methods:

• Enzyme inhibition assays using human leukocyte elastase and various chondroitin sulfate fractions.
• Kinetic analysis to classify the inhibition mechanism.
• Molecular mass and isomeric composition analysis of chondroitin sulfate fractions.

Main Results:

• Chondroitin sulfate partially inhibits human leukocyte elastase activity (up to 60%).
• The inhibition mechanism is hyperbolic noncompetitive and intersecting.
• Fractions with high molecular mass and a high proportion of chondroitin-6-sulfate exhibited significantly greater inhibitory potency (Ki = 1.8 µg/ml) compared to unfractionated or low molecular mass fractions.

Conclusions:

• Chondroitin sulfate modulates the activity of cartilage-degrading enzymes.
• Specific structural characteristics of chondroitin sulfate, namely high molecular mass and a high chondroitin-6-sulfate content, are crucial for potent inhibition of leukocyte elastase.
• These findings suggest a mechanism for the therapeutic benefits of chondroprotective agents in managing cartilage degradation.